| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26b2178291e45da1aa6dcc2da3798747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_324beb8b942a3a6ed1f1f576bcd76c45 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22 |
| filingDate |
1999-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da9e4f9297af31c318c33f6a869bae5f |
| publicationDate |
2001-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001181251-A |
| titleOfInvention |
Aspirin derivative, production method thereof, and anti-inflammatory agent containing the same as active ingredient |
| abstract |
(57) [Problem] To provide a novel aspirin derivative with reduced gastric mucosal damage. SOLUTION: (2-acetoxybenzoyl) glutamine is used as an active ingredient of an anti-inflammatory agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1843661-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010130396-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1843661-A2 |
| priorityDate |
1999-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |